TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07717346: A Study to Investigate Safety and Efficacy of KB111 for the Treatment of Hailey-Hailey Disease

Sponsor: Krystal Biotech, Inc. · Phase: PHASE1 · Area: DERMATOLOGY_AESTHETIC · Target Enrollment: 20 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$1,982,472

Rescue Site Savings

+$1,315,800

Unlock Full NCT07717346 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07717346 Rescue Dossier →